Invention Grant
US08481490B2 Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis
失效
在胰腺炎患者中减少血浆淀粉酶和/或血浆脂肪酶的方法
- Patent Title: Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis
- Patent Title (中): 在胰腺炎患者中减少血浆淀粉酶和/或血浆脂肪酶的方法
-
Application No.: US13567932Application Date: 2012-08-06
-
Publication No.: US08481490B2Publication Date: 2013-07-09
- Inventor: Krystyna Tatarkiewicz , David G. Parkes , Denis Roy , Bronislava Gedulin
- Applicant: Krystyna Tatarkiewicz , David G. Parkes , Denis Roy , Bronislava Gedulin
- Applicant Address: US CA San Diego US DE Wilmington
- Assignee: Amylin Pharmaceuticals, LLC,AstraZeneca Pharmaceuticals LP
- Current Assignee: Amylin Pharmaceuticals, LLC,AstraZeneca Pharmaceuticals LP
- Current Assignee Address: US CA San Diego US DE Wilmington
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61P3/10 ; A61P7/12 ; C07K14/605
Abstract:
The disclosure provides the use of GLP-1 receptor agonist compounds to treat pancreatitis (e.g., acute, chronic, hemorrhagic, necrotizing) in patients. The disclosure also provides the use of GLP-1 receptor agonist compounds to reduce elevated plasma amylase and/or lipase concentrations in patients. An exemplary GLP-1 receptor agonist compound is exenatide.
Public/Granted literature
- US20120295850A1 GLP-1 RECEPTOR AGONISTS TO TREAT PANCREATITIS Public/Granted day:2012-11-22
Information query
IPC分类:
